Goldman Sachs analyst Irma Sgarz downgrades Vitru (NASDAQ:VTRU) from Buy to Neutral.
HC Wainwright & Co. Reiterates Buy on Replimune Group, Raises Price Target to $50
HC Wainwright & Co. analyst Robert Burns reiterates Replimune Group (NASDAQ:REPL) with a Buy and raises the price target from $48 to $50.